2(top 9%)
Impact Factor
2.2(top 9%)
extended IF
66(top 6%)
H-Index
1.2K
authors
1.3K
papers
25.8K
citations
2.8K
citing journals
14.2K
citing authors

Most Cited Articles of COPD: Journal of Chronic Obstructive Pulmonary Disease

TitleYearCitations
Genetic epidemiology of COPD (COPDGene) study design2010749
St. George's Respiratory Questionnaire: MCID2005586
Identifying individuals with physcian diagnosed COPD in health administrative databases2009397
Minimal clinically important differences in COPD lung function2005332
Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale2005237
Alveolar macrophages as orchestrators of COPD2004235
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 20032004213
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention2008203
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ)2005200
The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and Design2005191
Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test2005190
COPD as a systemic disease2008171
The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review2010169
Approaches and recommendations for estimating minimally important differences for health-related quality of life measures2005158
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS)2008157
The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 19632013156
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality2012144
The MCID of the transition dyspnea index is a total score of one unit2005144
Dyspnea and activity limitation in COPD: mechanical factors2007140
Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis2009137
Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes2009136
Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial2004133
Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature2006130
Chronic obstructive pulmonary disease and socioeconomic status: a systematic review2012124
The clinical importance of dynamic lung hyperinflation in COPD2006120